A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Clinical trial NCT07063823 · COMPLETED
Trial details
- NCT number
- NCT07063823
- Sponsor
- Nielsen Fernandez-Becker
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-26
- Primary completion
- 2026-04-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.